Wed, January 16, 2013

by: WOPRAI

BOFI, MRLN, QCCO, EDS, DLA, MWG Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

XVG, HBOS, GCA, PXE, GBLI, RUSHB Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

EXM, WIT, DRL Expected To Be Down After Next Earnings Releases

by: WOPRAI

WPI, ABX, BIP, DOW, HMC Expected To Be Up Before Next Earnings Releases

by: WOPRAI

XLNX, ASBC Expected To Be Up After Next Earnings Releases

by: WOPRAI

DE, SPH, CEVA, JNJ, JCI Expected To Be Down Before Next Earnings Releases

by: WOPRAI

Rick Wise Maintained (BSX) at Strong Buy with Increased Target to $7 on, Jan 16th, 2013

by: WOPRAI

Anthony Paolone Downgraded (BXP) to Hold and Held Target at $116 on, Jan 16th, 2013

by: WOPRAI

Jeffrey Holford Maintained (BMY) at Strong Buy with Increased Target to $39 on, Jan 16th, 2013

by: WOPRAI

Melissa Fairbanks Downgraded (ARW) to Hold on, Jan 16th, 2013

by: WOPRAI

Anthony Paolone Upgraded (VNO) to Buy and Held Target at $95 on, Jan 16th, 2013

by: WOPRAI

John Heagerty Downgraded (WFC) to Hold on, Jan 16th, 2013

by: WOPRAI

Michael Nemeroff Upgraded (SNCR) to Buy and Increased Target to $261 on, Jan 16th, 2013

Tue, January 15, 2013

by: WOPRAI

Skilled Healthcare Group Inc (NYSE:SKH), Down By 6.41% ($0.36) From $5.620 After BUYINS.NET Report Predicted Stock Would Go Dow

by: WOPRAI

PKY SqueezeTrigger Price is $15.59. There is $32,495,034 That Short Sellers Still Need To Cover.

by: WOPRAI

HOLL SqueezeTrigger Price is $1.39. There is $2,940 That Short Sellers Still Need To Cover.

by: WOPRAI

GLF SqueezeTrigger Price is $34.19. There is $25,463,110 That Short Sellers Still Need To Cover.

by: WOPRAI

Advaxis Inc (OTC:ADXS), Down By 10.00% ($0.01) From $0.050 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish

by: WOPRAI

AUNFF, Removed From Naked Short Lists Today

by: WOPRAI

MLNX SqueezeTrigger Price is $52.39. There is $384,289,246 That Short Sellers Still Need To Cover.

by: WOPRAI

MAJESCO ENTERTAINMENT COMPANY (NASDAQ:COOL), Down By 5.56% ($0.06) From $1.080 After BUYINS.NET Report Predicted Weakness After

by: WOPRAI

Halozyme Therapeutics Inc (NASDAQ:HALO), Up By 13.17% ($0.98) After BUYINS.NET SqueezeTrigger Report Released on Monday, Janua

by: WOPRAI

ESEA, THI, TAL, NEWS, ZHNE, TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

QLTY, STAA, DRRX, SAPE, BAMM, NTGR Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

IGM, CCZ, DRAD, CRNT Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

UAL, SMCI, TRS, TLO, MVO, TLH Are Seasonally Ripe To Go Down In the Next Five Weeks

Michael Nemeroff Upgraded (SNCR) to Buy and Increased Target to $261 on, Jan 16th, 2013

Michael Nemeroff of Credit Suisse, Upgraded "Synchronoss Technologies, Inc." (SNCR) to Buy and Increased Target from $180 to $261 on, Jan 16th, 2013.

Michael has made no other calls on SNCR in the last 4 months.



There are 2 other peers that have a rating on SNCR. Out of the 2 peers that are also analyzing SNCR, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael

  • Gray Powell of "Wells Fargo" Upgraded from Hold to Buy on, Thursday, January 10th, 2013
  • Tom Roderick of "Stifel" Maintained at Strong Buy with Decreased Target to $288 on, Tuesday, November 6th, 2012